BML Investment Partners, L.P. 13D and 13G filings for Talis Biomedical Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-14 9:23 pm Purchase |
2024-08-14 | 13G | Talis Biomedical Corporation TLIS |
BML Investment Partners, L.P. | 203,569 11.200% |
69,484 (+51.82%) |
Filing |
| 2024-08-14 8:44 pm Purchase |
2024-08-07 | 13G | Talis Biomedical Corporation TLIS |
BML Investment Partners, L.P. | 134,085 7.400% |
134,085 (New Position) |
Filing |